Monopar Therapeutics Inc. Common Stock (MNPR) is a publicly traded Healthcare sector company. As of July 21, 2026, MNPR trades at $108.60 with a market cap of $744.40M and a P/E ratio of -58.03. MNPR moved +3.04% today. Year to date, MNPR is +62.75%; over the trailing twelve months it is +127.84%. Its 52-week range spans $18.81 to $115.00. Analyst consensus is strong buy with an average price target of $113.33. Rallies surfaces MNPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for MNPR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $108.60 |
| Market Cap | $744.40M |
| P/E Ratio | -58.03 |
| EPS | $-1.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $115.00 |
| 52-Week Low | $18.81 |
| Volume | 97.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.72M |
| Gross Margin | 0.00% |
9 analysts cover MNPR: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $113.33.